The clinical significance of equivocal findings on spinal MRI in children with medulloblastoma

被引:10
作者
Bennett, Julie [1 ]
Ashmawy, Ramy [2 ]
Ramaswamy, Vijay [1 ]
Stephens, Derek [3 ]
Bouffet, Eric [1 ]
Laperriere, Normand [4 ]
Taylor, Michael [5 ]
Shroff, Manohar [2 ]
Bartels, Ute [1 ]
机构
[1] Univ Toronto, Hosp Sick Children, Div Hematol Oncol, Dept Paediat, Toronto, ON, Canada
[2] Univ Toronto, Hosp Sick Children, Dept Diagnost Imaging, Div Neuroradiol, Toronto, ON, Canada
[3] Hosp Sick Children, Div Clin Res Serv, Res Inst, Toronto, ON, Canada
[4] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON, Canada
[5] Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada
关键词
medulloblastoma; MRI; staging; GADOPENTETATE DIMEGLUMINE; BRAIN-TUMORS; CSF CYTOLOGY; NERVE ROOTS; RECURRENCE; SUBGROUPS; RESECTION; SURGERY;
D O I
10.1002/pbc.26472
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMedulloblastoma (MB) is the most common malignant brain tumor of childhood, with cerebrospinal fluid spread the most common site of metastasis. Currently, children diagnosed with MB and evidence of spinal metastasis are treated with an increased dose of craniospinal radiation (CSI). This report reviewed equivocal abnormalities including nerve root clumping, linear vascular enhancement, nerve root enhancement and/or other vague findings on spinal magnetic resonance imaging (MRI) to elucidate their prognostic significance and aid in risk stratification. MethodsThis retrospective cohort study identified children (3 years) diagnosed with MB between 1988 and 2012. Children treated with upfront CSI were included, and staging spine MRI must have been done preoperatively or within 72 hr of primary tumor resection. Initial MRI of the spine was assessed by two independent reviewers blinded to outcome to evaluate for equivocal findings. Survival analysis was done to determine impact on prognosis. ResultsOne hundred of 157 patients were eligible for the analysis. Equivocal findings were identified in 48 (48%) patients, with MRI done preoperatively in 45 (94%) patients. Analysis by subgroup identified a higher proportion of equivocal findings in the sonic hedgehog (SHH) subgroup (P = 0.007). Five-year overall survival (OS) in children with equivocal findings compared to those with normal MRI was not different, 80 vs. 84.8% respectively, while OS in M3 patients was worse at 54.7% (P = 0.02). ConclusionA higher proportion of equivocal findings was identified in the SHH subgroup. This institutional retrospective review demonstrates equivocal findings are common, not associated with decreased OS and should not prompt increased dose of CSI.
引用
收藏
页数:6
相关论文
共 19 条
  • [1] EARLY POSTOPERATIVE MAGNETIC-RESONANCE-IMAGING AFTER RESECTION OF MALIGNANT GLIOMA - OBJECTIVE EVALUATION OF RESIDUAL TUMOR AND ITS INFLUENCE ON REGROWTH AND PROGNOSIS
    ALBERT, FK
    FORSTING, M
    SARTOR, K
    ADAMS, HP
    WILSON, CB
    KUNZE, S
    SALCMAN, M
    [J]. NEUROSURGERY, 1994, 34 (01) : 45 - 61
  • [2] Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor
    Fouladi, M
    Gajjar, A
    Boyett, JM
    Walter, AW
    Thompson, SJ
    Merchant, TE
    Jenkins, JJ
    Langston, LW
    Liu, AY
    Kun, LE
    Heideman, RL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3234 - 3237
  • [3] Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
    Gajjar, Amar
    Chintagumpala, Murali
    Ashley, David
    Kellie, Stewart
    Kun, Larry E.
    Merchant, Thomas E.
    Woo, Shaio
    Wheeler, Greg
    Ahern, Valerie
    Krasin, Matthew J.
    Fouladi, Maryam
    Broniscer, Alberto
    Krance, Robert
    Hale, Gregory A.
    Stewart, Clinton F.
    Dauser, Robert
    Sanford, Robert A.
    Fuller, Christine
    Lau, Ching
    Boyett, James M.
    Wallace, Dana
    Gilbertson, Richard J.
    [J]. LANCET ONCOLOGY, 2006, 7 (10) : 813 - 820
  • [4] Recent developments and current concepts in medulloblastoma
    Gerber, N. U.
    Mynarek, M.
    von Hoff, K.
    Friedrich, C.
    Resch, A.
    Rutkowski, S.
    [J]. CANCER TREATMENT REVIEWS, 2014, 40 (03) : 356 - 365
  • [5] Correlation of MRI and CSF cytology in the diagnosis of medulloblastoma spinal metastases
    Harrison, SK
    Ditchfield, MR
    Waters, K
    [J]. PEDIATRIC RADIOLOGY, 1998, 28 (08) : 571 - 574
  • [6] HUDGINS PA, 1991, AM J NEURORADIOL, V12, P301
  • [7] JINKINS JR, 1993, AM J NEURORADIOL, V14, P193
  • [8] Outcome of children with posterior fossa medulloblastoma: a single institution experience over the decade 1994-2003
    Kombogiorgas, D.
    Sgouros, S.
    Walsh, A. R.
    Hockley, A. D.
    Stevens, M.
    Grundy, R.
    Peet, A.
    English, M.
    Spooner, D.
    [J]. CHILDS NERVOUS SYSTEM, 2007, 23 (04) : 399 - 405
  • [9] LANE JI, 1994, AM J NEURORADIOL, V15, P1317
  • [10] Time window for postoperative reactive enhancement after resection of brain tumors: less than 72 hours
    Lescher, Stephanie
    Schniewindt, Sonja
    Jurcoane, Alina
    Senft, Christian
    Hattingen, Elke
    [J]. NEUROSURGICAL FOCUS, 2014, 37 (06)